November 10th, 8:30am to 6pm at the Anvil Centre, New Westminster, BC 

Doors open at 8:00am

This symposium brings together some of the leading experts from Canada, Italy and Spain to present the basic science research into the ECS and phytopharmacology of the Cannabis plant together with the best practices in the medical application of Medical Cannabis.

With over 20,000 articles published on Cannabis alone and another 9,000 articles on the ECS, it is imperative for medical practitioners to study the important role of the ECS and the therapeutic application of phytocannabinoids and related compounds on human health.

Research into the pharmacology of Cannabis led to the discovery of the Endocannabinoid System (ECS) n the 1990’s. The ECS is a vast fatty acid neurotransmitter system than acts as the largest homeostatic signalling system in the human body. The discovery of the 2 endocannabinoid receptors CB1 and CB2 and their ligands, anandamide and 2-AG has led to an impressive body of research into basic physiological control mechanisms and applications to disease cure and management in the areas of pain, inflammation, cancer, neurology, psychiatry, digestion, skin, metabolism to name a few. Ethan Russo’s proposal of an Endocannabinoid Deficiency Syndrome has led to interest I further medical applications of cannabinoid therapy in such areas as fibromyalgia, IBS and migraines. Further legalization for medical cannabis in the USA and Canada has led to an explosion of research into the phytocannabinoids, such as CBD and THC, terpenes and bioflavonoids all found in the Cannabis plant.

Meet the Medical Cannabis conference speakers:

CAROLINE MACCALLUM, BSc Pharm, MD – see bio

Practical Considerations for Medical Cannabis Administration and Dosing

EDUARDO MUNOZ, MD, PhD – see bio

The Endocannabinoid System as a Target for Neurodegenerative Diseases

GIOVANNI APPENDINO, PhD – see bio

Cannabis, a Historical Perspective: How Far We have Come and Still Need to Go

ZACH WALSH, PhD – see bio

Cannabis, Mental Health and Public Health

MICHAEL MURRAY, ND – see bio

Cannabinoid Research: Where We Are in Terms of Standardization and Efficacy

NEIL MCKINNEY, ND – see bio

Cannabis in Cancer Therapy

PAULA BROWN, PhD – see bio

Quality Control Issues with Cannabis

ANDREW MUROFF, MBA, JD – see bio

Data Driven Cannabis Treatment Guidance

STEFAN KUPROWSKY, MA, ND – see bio

The Wisdom of the Plant : an Ethnomedical Perspective

CHRIS SPOONER, BSc, ND – see bio

Endocannabinoid System

 

Approved for 8 hours Category C for CNPBC.

Contact ceinfo@binm.org for more information